Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082175 | SCV000114121 | benign | not specified | 2017-04-12 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000082175 | SCV000151162 | benign | not specified | 2015-06-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000082175 | SCV000196816 | benign | not specified | 2015-03-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Genetic Medicine Research, |
RCV000082175 | SCV000265793 | uncertain significance | not specified | 2015-12-01 | criteria provided, single submitter | research | |
Invitae | RCV000227473 | SCV000290697 | benign | Walker-Warburg congenital muscular dystrophy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000082175 | SCV000314266 | benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000711662 | SCV000603719 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV000577971 | SCV000679829 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000711662 | SCV000842049 | benign | not provided | 2017-09-06 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000577971 | SCV001737259 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001563823 | SCV001786859 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001563824 | SCV001786860 | benign | Muscular dystrophy-dystroglycanopathy type B5 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000082175 | SCV002051008 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000711662 | SCV002563538 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | FKRP: BS1, BS2 |
Ambry Genetics | RCV002453409 | SCV002612850 | benign | Cardiovascular phenotype | 2019-01-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000577971 | SCV001460333 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2020-06-12 | no assertion criteria provided | clinical testing |